Megaspeed Pledges Cooperation in Nvidia-Linked U.S. Probe
Megaspeed has reportedly pledged to cooperate with a U.S. investigation linked to Nvidia, but the allegations, investigating agency and companies’ legal statuses remain unclear.
Gold Tests $3,900 After U.S. Jobless Claims Rise
Gold tested $3,900 per ounce after U.S. weekly jobless claims rose to 200,000. Yields, the dollar and follow-through will determine whether the move becomes a breakout.
Apple HomeView Review: Is the $299 Smart Display Worth It?
Apple HomeView offers shared smart-home control through touch and Siri, but its $299 price, iPhone dependence, late arrival, and rough edges limit its appeal.
Why This Anker Universal Charger Is Ideal for Travel
The Anker 100W universal charger reduces travel clutter by powering compatible laptops, phones, tablets, and accessories from one compact wall adapter.
Google Gemini Smartglasses Start at $395, Lead With Privacy
Google’s Gemini-powered smartglasses start at $395, but their success may depend less on AI capability than on transparent privacy controls for users and bystanders.
Microsoft Study: AI Backdoors Need Fewer Than 10 Neurons
Reports on Microsoft research suggest that editing fewer than 10 neurons can implant a dormant backdoor in an AI agent, exposing risks in model integrity and tool access.
Prostate Cancer Screening Recommendations Explained
Learn what current prostate cancer screening recommendations mean, who may benefit from PSA testing, and how to weigh potential benefits and risks.
US Measles History and PAHO Elimination Review
PAHO is reviewing whether the United States still meets measles-elimination criteria after renewed transmission raised concerns about domestic outbreak control.
Ebola in DR Congo: MSF Raises Funding Concerns
MSF has warned that millions allocated to the Ebola response in DR Congo may be unaccounted for, raising concerns about oversight and outbreak control.
Tourette’s Device Offers Hope for Reducing Tics
A wrist-worn, non-invasive device reduced tics in a University of Nottingham trial, offering hope while researchers stress that it is not a cure.